Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Clorox (CLX)

NYSE: CLX · Household Products · Oakland, CA

Our rating: Positive

Positive reaffirmed at $93.80, moderate conviction, November 3, 2026.

Breaks if: The positive call is broken if revenue declines more than 2% year-over-year in the next annual filing, or if free-cash-flow margin slips below 9% for two consecutive quarterly reporting periods — either would confirm the flat top line has become a structural earnings problem rather than a temporary lull. A drawdown of 20% or more over the next twelve months without any fundamental improvement would signal the market sees deterioration not yet visible in the reported figures.

Key figures

Market value$12.7B
Revenue, last 12 monthsn/a
Net income, last 12 monthsn/a
Free cash flow, last 12 monthsn/a
Price to earningsn/a
Free cash flow yieldn/a
Dividend yield4.8%
Operating marginn/a
Return on equityn/a
Beta to the S&P 5000.23
Volatility, annualized26.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.9B33.3%$1.39$105M
March 31, 2026$1.7B0.1%$1.54−$165M
December 31, 2025$1.7B−0.8%$1.29$269M
September 30, 2025$1.4B−18.9%$0.65$57M
June 30, 2025$2.0B4.5%$2.68$219M
March 31, 2025$1.7B−8.0%$1.50$233M
December 31, 2024$1.7B−15.3%$1.54$127M
September 30, 2024$1.8B27.1%$0.80$182M

14 ledger entries and 36 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.